CClinicalTrials.gg
Enrolling by invitationNCT07824284Updated Sep 17, 2026

Ultrasound-assisted vs Palpation-guided Lumbar Punctures

An interventional study of Ultrasound-Assisted Lumbar Puncture and Standard Palpation-Guided Lumbar Puncture in Lumbar Puncture, sponsored by The Cooper Health System. Enrolling by invitation at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by The Cooper Health System · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized clinical trial is to determine whether ultrasound-assisted lumbar puncture improves first-needle insertion success compared with the standard palpation technique in adults undergoing a clinically indicated lumbar puncture.

The primary question is whether pre-procedural ultrasound localization increases the likelihood of successful cerebrospinal fluid collection on the first needle insertion. The study will also evaluate overall procedural success, the number of needle insertions and redirections, procedure time, the need for subsequent image-guided lumbar puncture, traumatic tap, procedural and post-procedural pain, and post-dural puncture headache.

Participants will be randomly assigned in a 1:1 ratio to undergo lumbar puncture using either pre-procedural ultrasound localization or standard palpation of anatomical landmarks.

Read the detailed description

Lumbar puncture (LP) is a commonly performed diagnostic and therapeutic procedure. The standard approach relies on palpation of surface anatomical landmarks to identify an appropriate intervertebral space for needle insertion. When landmarks are difficult to identify, LP may require multiple needle insertions or redirections, cause greater patient discomfort, delay cerebrospinal fluid (CSF) collection, or require a subsequent image-guided procedure.

Point-of-care ultrasound can be used before needle insertion to identify the spinal midline and an appropriate interspinous space and to estimate the depth to the target. Previous studies of ultrasound-assisted LP have produced variable findings regarding procedural success, efficiency, traumatic tap, and patient discomfort. Patient-centered complications, including post-dural puncture headache, have been less extensively evaluated.

This is a prospective, multicenter, parallel-group randomized controlled trial involving adults undergoing a clinically indicated LP in an inpatient or outpatient setting. Participants will be randomly assigned in a 1:1 ratio to pre-procedural ultrasound localization or standard palpation of anatomical landmarks.

In the ultrasound-assisted group, point-of-care ultrasound will be used before needle insertion to identify the spinal midline and interspinous space and estimate the depth to the target. The selected insertion site will then be marked, and the LP will proceed using standard technique; the needle will not be advanced under real-time ultrasound guidance. In the standard palpation group, the insertion site will be identified by palpation without pre-procedural ultrasound. Other aspects of the procedure and post-procedure care will follow standard clinical practice at each participating site.

The trial will determine whether pre-procedural ultrasound localization improves first-needle insertion success and reduces procedural burden and complications compared with standard palpation.

02

Conditions studied

  • Lumbar Puncture

Keywords

  • lumbar puncture
  • ultrasound-guided lumbar puncture
  • ultrasound-assisted lumbar puncture
  • point-of-care ultrasound
  • palpation-guided lumbar puncture
  • first-attempt success
  • post-dural puncture headache
  • multicenter
  • inpatient
  • outpatient
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 18 years old and above
  • Patients requiring lumbar puncture for diagnostic or therapeutic purposes as determined by the treating physician
  • Must be able to give informed consent, or if unable, have a legally authorized representative provide written consent

Exclusion criteria

Exclusion Criteria:

  • Inability to safely undergo bedside lumbar puncture (either ultrasound-guided or palpation guided) as determined by the treating physician
  • Known contraindications to lumbar puncture, including:
  • Increased intracranial pressure with risk of herniation
  • Infection at the lumbar puncture site
  • Known coagulopathy or platelet count \<50,000 µL
  • Received DVT prophylaxis on the day of planned lumbar puncture
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Ultrasound-assisted

    Participants undergo pre-procedural point-of-care ultrasound to identify and mark the spinal midline, selected interspinous spaces and to estimate the depth to the target. The lumbar puncture is then performed using standard technique without real-time ultrasound guidance.

    Procedure: Ultrasound-Assisted Lumbar Puncture

  • Active comparator
    Standard Palpation-Guided

    The lumbar puncture insertion site is selected by palpation of anatomical landmarks without pre-procedural ultrasound localization. The lumbar puncture is then performed using standard technique.

    Other: Standard Palpation-Guided Lumbar Puncture

Interventions

  • ProcedureUltrasound-Assisted Lumbar Puncture

    Pre-procedural point-of-care ultrasound is used to identify the midline, appropriate interspinous space, and estimated needle depth. The selected insertion site is marked, after which lumbar puncture is performed using standard sterile technique and institutional protocols.

  • OtherStandard Palpation-Guided Lumbar Puncture

    Anatomical landmarks are identified by palpation of bony landmarks to select the lumbar puncture insertion site. Lumbar puncture is then performed using standard sterile technique and institutional protocols without pre-procedural ultrasound localization.

05

What researchers measure

Primary outcomes

  1. First Attempt Lumbar Puncture Success

    First-attempt success is defined as successful cerebrospinal fluid (CSF) return following a single skin puncture, without complete withdrawal and reinsertion of the lumbar puncture needle. Up to three in-situ needle redirections are permitted. A redirection is defined as partial withdrawal and readvancement of the needle without removal from the skin.

    Time frame: During the lumbar puncture procedure

Secondary outcomes

  1. Overall Lumbar Puncture Success

    Successful CSF return during the initially assigned lumbar puncture procedure, regardless of the number of needle reinsertions or redirections and without requiring a subsequent fluoroscopy-guided lumbar puncture.

    Time frame: During the initial lumbar puncture encounter

  2. Number of Needle Reinsertions

    Number of times the lumbar puncture needle is completely withdrawn from the skin and reinserted during the procedure.

    Time frame: During the lumbar puncture procedure

  3. Number of Needle Redirections

    Number of times the needle is partially withdrawn and readvanced along a different trajectory without complete removal from the skin.

    Time frame: During the lumbar puncture procedure

  4. Procedure Time

    Elapsed time in minutes from initiation of landmark identification using ultrasound or palpation until CSF return. For an unsuccessful procedure, time is measured until termination of the assigned bedside procedure.

    Time frame: During the lumbar puncture procedure

  5. Time to CSF Return

    Time in minutes from the first skin puncture with the lumbar puncture needle to successful CSF return.

    Time frame: During the lumbar puncture process

  6. Incidence of Traumatic Tap

    Proportion of participants with a traumatic lumbar puncture, defined as a CSF red blood cell count ≥400 cells/µL in the first collection tube with a decrease in red blood cell count in the fourth tube.

    Time frame: During the lumbar puncture procedure

  7. Incidence of Radicular Pain During Lumbar Puncture

    Proportion of participants reporting radicular pain during the lumbar puncture procedure.

    Time frame: During the lumbar puncture procedure

  8. Post-Procedural Back Pain

    Participant-reported pain at the lumbar puncture site, measured using a numeric rating scale from 0 to 10, with higher scores indicating greater pain.

    Time frame: Within 24-48 hours after lumbar puncture

  9. Incidence of Post-Dural Puncture Headache

    Proportion of participants who develop a post-dural puncture headache meeting International Classification of Headache Disorders, Third Edition criteria.

    Time frame: Within 5 days after lumbar puncture

  10. Need for Fluoroscopic-Guided Lumbar Puncture

    Proportion of participants requiring subsequent fluoroscopic-guided lumbar puncture after unsuccessful completion of the initially assigned lumbar puncture procedure.

    Time frame: Within 7 days after the initial bedside lumbar puncture attempt

  11. Hospitalization Related to Lumbar Puncture Complications

    Hospitalization due to lumbar puncture-related complications, including prolonged hospitalization for inpatients or new hospital admission for outpatients.

    Time frame: Within 1 month of lumbar puncture.

06

Study locations

2 sites
  • Cooper University Hospital
    Camden, New Jersey 08103, United States
  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213, United States
07

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported from this study may be made available to qualified researchers upon reasonable request, along with a data dictionary, subject to applicable institutional and regulatory requirements.

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07824284
Lead sponsor
The Cooper Health System
Responsible party
Swarna Rajagopalan (Associate Professor of Neurology, Attending Physician, Neurocritical Care, Principal Investigator, The Cooper Health System) — Principal investigator
First posted
Sep 17, 2026
Start date
Apr 25, 2026
Primary completion
Jun 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Sep 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion